Zomig and Prochlorperazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zomig (zolmitriptan) and Prochlorperazine (prochlorperazine). Common drug interactions include feeling hot among females and asthma among males.

The phase IV clinical study analyzes what interactions people have when they take Zomig and Prochlorperazine. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Zomig?

Zomig has active ingredients of zolmitriptan. It is often used in migraine. eHealthMe is studying from 7,356 Zomig users. Check the latest studies of Zomig.

What is Prochlorperazine?

Prochlorperazine has active ingredients of prochlorperazine. It is often used in nausea. eHealthMe is studying from 14,632 Prochlorperazine users. Check the latest studies of Prochlorperazine.



On Jul, 26, 2026

15 people who take Zomig and Prochlorperazine together, and have interactions are studied.

Zomig and Prochlorperazine drug interactions.

What are the common drug interactions of Zomig and Prochlorperazine, by gender? *:

female:

  1. Feeling hot
  2. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  3. Sjogren's syndrome (a disease that causes dryness in the mouth and eyes)
  4. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  5. Abdominal discomfort
  6. Abdominal pain upper
  7. Abnormal dreams
  8. Affective disorder (mental disorder)
  9. Anaemia (lack of blood)
  10. Anxiety

male:

  1. Asthma
  2. Back disorder
  3. Respiratory distress (difficulty in breathing)
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  5. Headache (pain in head)
  6. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  7. Pancreatitis (inflammation of pancreas)
  8. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  9. Rash
  10. Adverse reaction

What are the common drug interactions of Zomig and Prochlorperazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Arrhythmia (irregular heartbeat)
  2. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

30-39:

n/a

40-49:

  1. Abnormal dreams
  2. Affective disorder (mental disorder)
  3. Anxiety
  4. Mood swings (an extreme or rapid change in mood)

50-59:

  1. Asthma
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Pneumonitis (inflammation of the walls of the alveoli in the lungs)
  4. Feeling hot
  5. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  6. Sjogren's syndrome (a disease that causes dryness in the mouth and eyes)
  7. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  8. Adverse reaction
  9. Bronchospasm (spasm of bronchial smooth muscle producing narrowing of the bronchi)
  10. Respiratory distress (difficulty in breathing)

60+:

  1. Back disorder
  2. Headache (pain in head)
  3. Decreased appetite
  4. Dry mouth
  5. Fatigue (feeling of tiredness)
  6. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  7. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  8. Pancreatitis (inflammation of pancreas)
  9. Rash
  10. Abdominal discomfort

What are the existing conditions these people have? *

  1. Lung Cancer - Non-Small Cell (lung cancer): 2 people, 13.33%
  2. Quit Smoking: 2 people, 13.33%
  3. Pain: 2 people, 13.33%
  4. Headache (pain in head): 2 people, 13.33%
  5. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 13.33%
  6. Type 2 Diabetes: 1 person, 6.67%
  7. Bipolar Disorder (mood disorder): 1 person, 6.67%
  8. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 6.67%
  9. Cholangiocarcinoma (a cancer that forms glands or secretes significant amounts of mucins): 1 person, 6.67%
  10. Depression: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Zomig and Prochlorperazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Zomig and Prochlorperazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Zomig:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Prochlorperazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zomig and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Prochlorperazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on zolmitriptan and prochlorperazine (the active ingredients of Zomig and Prochlorperazine, respectively), and Zomig and Prochlorperazine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: